Table 1 Comparison of characteristics of patients in short-term (ST) and long-term (LT) group 6 months after withdrawal
ST group N = 20 | LT group N = 20 | p | |
|---|---|---|---|
Age (years) | 31 (28.3–35.5) | 32 (26–40) | 0.770 |
Body weight (kg) | 96 (76–116) | 87 (73–105) | 0.586 |
BMI (kg/m2) | 33.3 (26.6–39.7) | 32.5 (28.1–37.8) | 0.964 |
Waist circumference (cm) | 107 (89.5–118.5) | 102 (90–113) | 0.440 |
Systolic blood pressure (mmHg) | 123 (113.5–137.5) | 118 (111–122) | 0.170 |
Diastolic blood pressure (mmHg) | 84 (80–103.5) | 85 (74–86) | 0.142 |
No. of menstrual bleeding in last 6 month | 6 (4.5–6) | 6 (4–6) | 0.586 |
TFEQ-R18: cognitive restraint (%) | 61.1 (45.8–84.7) | 47.2 (37.5–61.1) | 0.085 |
TFEQ-R18: emotional eating (%) | 22.2 (13.9–52.8) | 33.3 (11.1–58.3) | 0.631 |
TFEQ-R18: uncontrolled eating (%) | 33.3 (10.2–40.7) | 29.6 (18.5–42.6) | 0.631 |
Total cholesterol (nmol/L) | 4.6 (3.1–6.1) | 4.9 (4.3–5.2) | 0.786 |
HDL (mmol/L) | 1.4 (1.1–1.7) | 1.6 (1.2–1.7) | 0.496 |
LDL (mmol/L) | 2.1 (1.6–3.6) | 2.5 (2.1–3.1) | 0.339 |
TG (mmol/L) | 1.4 (0.8–2) | 1.3 (0.8–1.9) | 0.964 |
FSH (IU/L) | 5.2 (3.3–6.2) | 5.4 (3.2–6.3) | 0.683 |
LH (IU/L) | 9.5 (5.3–16.2) | 6.1 (2.8–8.4) | 0.130 |
SHBG (nmol/L) | 32.6 (20.4–75.7) | 39.7 (32.5–56.5) | 0.458 |
Total testosterone (nmol/L) | 0.83 (0.69–1.5) | 0.73 (0.69–1.36) | 0.618 |
FAI score (%) | 3 (1–4) | 2 (2–3) | 0.440 |
Free testosterone (pmol/L) | 5.8 (4.9–7.2) | 6.9 (4.8–7.5) | 0.496 |
Androstenedione (nmol/L) | 6.8 (4.6–9.9) | 7.8 (4.8–9.6) | 0.683 |
Glucose OGTT 0 (mmol/L) | 4.9 (4.5–5.5) | 5.3 (4.7–5.6) | 0.316 |
Glucose OGTT 120 (mmol/L) | 5.5 (4.2–7.3) | 5.4 (4–6.5) | 0.586 |
Insulin OGTT 0 (mU/L) | 8.8 (2.3–21.9) | 6.6 (2.6–12.9) | 0.586 |
Insulin OGTT 120 (mU/L) | 66.5 (37.2–174.5) [3] | 45.7 (43.1–81.3) | 0.170 |
HOMA-IR score | 1.7 (0.5–4.9) | 1.6 (0.5–2.7) | 0.786 |